Terms: = Colorectal cancer AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK AND Treatment
174 results:
1. Outcomes Among Racial and Ethnic Minority Patients With Advanced cancers in Phase 1 Trials: A Meta-Analysis.
Goel S; Negassa A; Ghalib MH; Chaudhary I; Desai K; Shah U; Swami U; Cohen B; Maitra R; Mani S
JAMA Netw Open; 2024 Jul; 7(7):e2421485. PubMed ID: 38990570
[TBL] [Abstract] [Full Text] [Related]
2. Progress in clinical diagnosis and treatment of colorectal cancer with rare genetic variants.
Chen S; Gu J; Wu K; Zhao X; Lu Y
Cancer Biol Med; 2024 Jun; 21(6):473-83. PubMed ID: 38940668
[TBL] [Abstract] [Full Text] [Related]
3. IMMUNOREACT 7: Regular aspirin use is associated with immune surveillance activation in colorectal cancer.
Simoni O; Scarpa M; Castagliuolo I; Stepanyan A; Angriman I; Kotsafti A; Nacci C; Scognamiglio F; Negro S; D'Angelo A; Chiminazzo V; Businello G; Ruffolo C; Salmaso R; Franzato B; Gruppo M; Pilati P; Scapinello A; Pozza A; Stecca T; Massani M; Cataldo I; Brignola S; Dei Tos AP; Ceccon C; Guzzardo V; Vignotto C; Facci L; Maretto I; Agostini M; Marchegiani F; Becherucci G; Zizzo M; Bordignon G; Merenda R; Pirozzolo G; Recordare A; Pozza G; Godina M; Mondi I; Verdi D; Lio CD; Laurino L; Saadeh L; Rivella G; Guerriero S; Romiti C; Portale G; Cipollari C; Spolverato YC; Noaro G; Cola R; Candioli S; Gavagna L; Ricagna F; Ortenzi M; Guerrieri M; Tagliente G; Tomassi M; Tedeschi U; Salmaso B; Buzzi G; Parini D; Prando D; Zuin M; Bergamo F; Zagonel V; Porzionato A; Cavallin F; Camillo BD; Cristoforo LD; Bao QR; Pucciarelli S; Bardini R; Spolverato G; Fassan M; Scarpa M;
Cancer; 2024 Jul; 130(13):2272-2286. PubMed ID: 38644692
[TBL] [Abstract] [Full Text] [Related]
4. Nomograms integrating the collagen signature and systemic immune-inflammation index for predicting prognosis in rectal cancer patients.
Yu X; Jiang W; Dong X; Yan B; Xu S; Lin Z; Zhuo S; Yan J
BJS Open; 2024 Mar; 8(2):. PubMed ID: 38513282
[TBL] [Abstract] [Full Text] [Related]
5. Epigenetic MLH1 silencing concurs with mismatch repair deficiency in sporadic, naturally occurring colorectal cancer in rhesus macaques.
Deycmar S; Johnson BJ; Ray K; Schaaf GW; Ryan DP; Cullin C; Dozier BL; Ferguson B; Bimber BN; Olson JD; Caudell DL; Whitlow CT; Solingapuram Sai KK; Romero EC; Villinger FJ; Burgos AG; Ainsworth HC; Miller LD; Hawkins GA; Chou JW; Gomes B; Hettich M; Ceppi M; Charo J; Cline JM
J Transl Med; 2024 Mar; 22(1):292. PubMed ID: 38504345
[TBL] [Abstract] [Full Text] [Related]
6. Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer.
Shitara K; Muro K; Watanabe J; Yamazaki K; Ohori H; Shiozawa M; Takashima A; Yokota M; Makiyama A; Akazawa N; Ojima H; Yuasa Y; Miwa K; Yasui H; Oki E; Sato T; Naitoh T; Komatsu Y; Kato T; Mori I; Yamanaka K; Hihara M; Soeda J; Misumi T; Yamamoto K; Yamashita R; Akagi K; Ochiai A; Uetake H; Tsuchihara K; Yoshino T
Nat Med; 2024 Mar; 30(3):730-739. PubMed ID: 38347302
[TBL] [Abstract] [Full Text] [Related]
7. Development and validation of epigenetic modification-related signals for the diagnosis and prognosis of colorectal cancer.
Li X; Li J; Li J; Liu N; Zhuang L
BMC Genomics; 2024 Jan; 25(1):51. PubMed ID: 38212708
[TBL] [Abstract] [Full Text] [Related]
8. Site specific genetic differences in colorectal cancer via Next-Generation-Sequencing using a multigene panel.
Rencuzogullari A; Bisgin A; Erdogan KE; Gumus S; Yalav O; Boga I; Sonmezler O; Eray IC
Ann Ital Chir; 2023; 94():605-611. PubMed ID: 38131395
[TBL] [Abstract] [Full Text] [Related]
9. CT versus MR guidance for radiofrequency ablation in patients with colorectal liver metastases: a 10-year follow-up favors MR guidance.
Pereira PL; Siemou P; Rempp HJ; Hoffmann R; Hoffmann RT; Kettenbach J; Clasen S; Helmberger T
Eur Radiol; 2024 Jul; 34(7):4663-4671. PubMed ID: 38041717
[TBL] [Abstract] [Full Text] [Related]
10. Negative hyperselection of elderly patients with RAS and BRAF wild-type metastatic colorectal cancer receiving initial panitumumab plus FOLFOX or 5-FU/LV.
Pietrantonio F; Bergamo F; Rossini D; Ghelardi F; De Grandis MC; Germani MM; Barsotti G; Formica V; Frassineti GL; Boscolo G; Cinieri S; Di Donato S; Antonuzzo L; Antoniotti C; Ambrosini M; Piva VM; Nichetti F; Fassan M; Cremolini C; Lonardi S
Eur J Cancer; 2023 Dec; 195():113396. PubMed ID: 37924647
[TBL] [Abstract] [Full Text] [Related]
11. Characteristics and outcomes of rectal cancer in patients with inflammatory bowel disease: a single-center experience.
Emile SH; Horesh N; Garoufalia Z; Rogers P; Gefen R; Dasilva G; Wexner SD
Updates Surg; 2024 Jan; 76(1):119-126. PubMed ID: 37814150
[TBL] [Abstract] [Full Text] [Related]
12. A Meta-Analysis to Assess the Efficacy of HER2-Targeted treatment Regimens in HER2-Positive Metastatic colorectal cancer (mCRC).
Chitkara A; Bakhtiar M; Sahin IH; Hsu D; Zhang J; Anamika F; Mahnoor M; Ahmed R; Gholami S; Saeed A
Curr Oncol; 2023 Sep; 30(9):8266-8277. PubMed ID: 37754515
[TBL] [Abstract] [Full Text] [Related]
13. Targeted Therapy for cancers: From Ongoing Clinical Trials to FDA-Approved Drugs.
Choi HY; Chang JE
Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686423
[TBL] [Abstract] [Full Text] [Related]
14. [Analysis of prognosis and related factors in oldest-old patients with left-side or right-side colon cancer after hemicolectomy].
An Q; Shi JX; Cui J; Li ZJ; Ma FH; Xiao G; Jia WW; Tang DN; Zhao G; Wu GJ
Zhonghua Yi Xue Za Zhi; 2023 Jun; 103(22):1666-1672. PubMed ID: 37302856
[No Abstract] [Full Text] [Related]
15. Factors Affecting the Efficacy of Regorafenib in Metastatic colorectal cancer: Is Tumour Sidedness Important?
Kazaz SN; Ozdover AC; Usta N; Yildirim A; Fidan E; Ozdemir F
J Coll Physicians Surg Pak; 2023 Jun; 33(6):659-665. PubMed ID: 37300262
[TBL] [Abstract] [Full Text] [Related]
16. SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted Therapy.
Drilon A; Sharma MR; Johnson ML; Yap TA; Gadgeel S; Nepert D; Feng G; Reddy MB; Harney AS; Elsayed M; Cook AW; Wong CE; Hinklin RJ; Jiang Y; Brown EN; Neitzel NA; Laird ER; Wu WI; Singh A; Wei P; Ching KA; Gaudino JJ; Lee PA; Hartley DP; Rothenberg SM
Cancer Discov; 2023 Aug; 13(8):1789-1801. PubMed ID: 37269335
[TBL] [Abstract] [Full Text] [Related]
17. Timing of rectal cancer surgery after short-course radiotherapy: national database study.
Verweij ME; Franzen J; van Grevenstein WMU; Verkooijen HM; Intven MPW
Br J Surg; 2023 Jun; 110(7):839-845. PubMed ID: 37172197
[TBL] [Abstract] [Full Text] [Related]
18. Mutations in Classical Signaling Pathways and Their Functional Impact in Microsatellite Instability High colorectal cancer.
Shi S; Gong Y; Li X; Ding Y; Song G; Liu H; Zhang Z
Genet Test Mol Biomarkers; 2023 Mar; 27(3):90-99. PubMed ID: 36989521
[No Abstract] [Full Text] [Related]
19. Early evaluation of liver metastasis using spectral CT to predict outcome in patients with colorectal cancer treated with FOLFOXIRI and bevacizumab.
Li S; Yuan L; Yue M; Xu Y; Liu S; Wang F; Liu X; Wang F; Deng J; Sun Q; Liu X; Xue C; Lu T; Zhang W; Zhou J
Cancer Imaging; 2023 Mar; 23(1):30. PubMed ID: 36964617
[TBL] [Abstract] [Full Text] [Related]
20. Inflammatory myofibroblastic tumor of the mesentery with a SQSTM1::alk fusion responding to alectinib.
Sunga CGG; Higgins MS; Ricciotti RW; Liu YJ; Cranmer LD
Cancer Rep (Hoboken); 2023 Mar; 6(3):e1792. PubMed ID: 36754839
[TBL] [Abstract] [Full Text] [Related]
[Next]
